Meditation Mobile App Developed for Patients With and Survivors of Cancer: Feasibility Randomized Controlled Trial
BackgroundTo address the unmet need for a commercial cancer-specific meditation app, we leveraged a long-standing partnership with a consumer-based app (ie, Calm) to develop the first commercial meditation app prototype adapted specifically for the needs of patients with canc...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2022-11-01
|
Series: | JMIR Cancer |
Online Access: | https://cancer.jmir.org/2022/4/e39228 |